The graphical representation shows an R squared value of 0.0013 for Saniprazole mkII and 0.00 for Saniprazole, highlighting the time period it takes for remission to occur in the use and cessation use of Saniprazole and Saniprazole mkII, with Saniprazole mkII geared to treatment of EoE on extended duration of remission symptoms.

Confirmation to the FDA CDER next gen portal for Emepi-CMP001, Saniprazole, Saniprazole mkII and Emepi- CMP001 Intravenous for INDs NDAs on Orphan status in reciept of an Acknolodgement letter to request applications.

Made submissions to the FDA CDER next gen portal for Emepi-CMP001, Saniprazole, Saniprazole mkII and Emepi- CMP001 Intravenous for INDs NDAs on addendum and request numbers 00281366, 00281365, 00281363.

Made submissions to the FDA CDER next gen portal for Emepi-CMP001, Saniprazole, Saniprazole mkII and Emepi- CMP001 Intravenous

Made inquiry and submitted documentations for a pre-qualification of medicine status.

In efforts to generate funds towards operational functions to certain aspects of DIOIC, DIOIC, owner, founder and ceo is currently undergoing prospects to consultaion with certain organizations towards generating funding, and proposals have been made to Arsenal Fc in partnership to certain functional operation, sustainable to employment as a consultant to player evaluation and tactical aspects to a team formation as a passionate fan towards assistance by DIOIC ceo owner and founder Orighoye Dennis Iyonsi, a consultation and partnership with parent company Aventiv with Securus Technologies and Jpay towards a solution resolution to business and to a streamlined operational function in transitioning inmates back into society, with the United Nations in solution conflict resolutionary position and also an economic straddling solution to homelessness with UNDP in contact to a friend and the United Nations offices, with the office of governorship with California and the regional chamber of commerce. With confirmational agreements to follow with announcements to be made in regards to partnership and consultation with highlighted organizations; agreement to monetary contribution have already been agreed to by the following organizations, Arsenal Fc and Aventiv with Securus Technologies and Jpay with finalization and announcement to follow.

Current developments with DIOIC Biologics is in contact with NAFDAC (National Agency for Food and Drug Administration and Control) for requests to drug approvals of DRUGS with conducted trials and studies.

Legal Correspondence Letter

Current developments confirms functionality and workability of IP properties in Vitality as a model organism for physiological and biochemical tests and Munonera for detection of Cancer and other biological malignments, confirming proof of Ideation and Intellectual property to a working function.

Provided updates to DIOIC Biologics with BfArm, the drug regulatory body of Germany for Saniprazole, Saniprazole mkII and Emepi towards regulatory approvals and review in furnishing updates to study datas and trial documentations.

Currently In discussions and negotiations with my Partner and Wife, Jillian Rose Banks Iyonsi for production and manufacturing of Sporting Apparel Node(Edon)and DIO Industries Corporation for sporting-wares attires with hoodies, t-shirts and moving on on designs for utility wares.

Made contact with Deutsche Bank for credit-line access, assistance with brokerage of IP properties wanting offloading, as well as financing loans for operational activities with DIOIC.

Made contact with Drug and health product review and approval for Emepi, Saniprazole and Saniprazole mkII for Extraordinary Use New Drug Submission (EUNDS), New Drug Submission (NDS) and an application for a Drug Identification Number for a pharmaceutical product, including non-prescription products attesting to a Labelling Standard (DINA) for division 1 drugs.

DIO Industries Corporporation is currently in negotiation in provision of an offer for Acquisition of FogHorn Therapeutics Inc [FHTX] and have made contact in regards towards a full acquisition of FogHorn Therapeutics INC . 20th of December 2024.

In request from the Veterans Affairs [VA] to purchase 3,900,156 Emepi pill tablets and 757,714.29 Emepi Syringe Fluid of 0.2 - 0.3ml Emepi fluid containers.

Currently have Three medications in review with the FDA, agreements to supply currently in progress with requests, and research and developments ongoing in other facets of DIOIC

Conclusion to the 5 day 'tree-bark' study passed for treatment of moderate to severe pain with Emepi - CMP001.

DIO Industries Corporporation is currently in a preminilary Interest in Acquisition of BioAmerica Incorporated and have made contact in regards, towards a full acquisition of BioAmerica Incorporated. 12th of September 2024.

DIO Industries Corporporation is currently in discussion with the Indonesian Government in a partial Acquisition of Kimia Farma and have made contact in regards, towards a partial controlling acquisition of Kimia Farma. 17th of September 2024.

Business and Current Developments

Gastreointestinal Publication on EoE and Gerd with Saniprazole and Saniprazole mkII